News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Four Reasons Merck & Co., Inc. (MRK)'s R&D Restructuring May Not Save The Drug Giant


12/30/2013 8:22:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Last Friday, Wall Street Journal reporters Peter Loftus and Jonathan Rockoff broke the story that Merck is planning a dramatic R&D restructuring. The goal is to look externally for more programs, rather than to count on Merck’s legendary research labs to provide the bulk of the pipeline. Four “innovation hubs” will be created, based near Boston, San Francisco, London, and Shanghai.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES